ArticleFrontiers in oncology2026
Clinical features, diagnostic difficulties and therapeutic enlightenment of adult-onset multisystem Langerhans cell histiocytosis complicated with panhypopituitarism and central diabetes insipidus: a case report and systematic literature review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adult-onset Langerhans cell histiocytosis (LCH) involving the hypothalamic-pituitary region (HPR) is a rare and diagnostically challenging neoplasm, often presenting with severe neuroendocrine dysfunction. This report details the case of a young adult female who presented with panhypopituitarism and central diabetes insipidus (CDI) as the initial manifestation of multisystem LCH. The diagnostic journey, complicated by non-specific radiological findings mimicking common sellar pathologies, ultimately required histopathological confirmation via CD1a and S-100 immunohistochemistry. Management involved a multidisciplinary approach, yet the patient exhibited a suboptimal response to initial systemic chemotherapy, reflecting the refractory nature of adult multisystem disease. Partial remission was eventually achieved following salvage radiotherapy to the residual hypothalamic lesion. This case underscores the critical need to include LCH in the differential diagnosis of sellar masses with extensive endocrine dysfunction, highlights the diagnostic imperative of immunohistochemistry, and illustrates the therapeutic challenges and the enduring role of radiotherapy in managing refractory adult HPR-LCH, thereby contributing to the optimization of individualized management strategies for this complex disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.